Latest Asx Compliance News

Advanced Innergy Holdings Ltd has responded to ASX inquiries denying any media leak regarding its proposed $0.40 cash bid for Matrix Composites & Engineering, reaffirming its commitment to strict disclosure policies.

SQX Resources has addressed an ASX compliance query regarding director Bevan Tarratt’s trading during a closed period, confirming prior board approval and an administrative disclosure error.

American Tungsten and Antimony Ltd has addressed discrepancies between initial visual estimates and assay results for stibnite mineralisation at its Antimony Canyon Project, revealing challenges in distinguishing mineral types visually and outlining steps to improve reporting accuracy.

Killi Resources has appointed former Fortescue CEO Nev Power as Non-Executive Chair and secured $1.4 million through a share placement led by Power and other key executives. The capital will support exploration at Mt Rawdon West and new growth initiatives.

ASX Compliance has formally queried Reckon Limited regarding a late filing of a director interest notice, raising potential breaches of key listing rules. The company must respond swiftly to avoid trading disruptions.

Merino & Co. Limited has attributed the late lodgement of director interest notices to an administrative oversight and reaffirmed its compliance measures to meet ASX disclosure rules.

Lachlan Star Limited has provided important clarifications on visible gold imagery from its New Waverley project, confirming high-grade assay results while cautioning on the qualitative nature of visual gold observations.

OZZ Resources Limited has announced a fully underwritten entitlement offer to raise approximately $1.07 million, aiming to convert debt and fund project opportunities while addressing its ongoing ASX suspension. The offer carries significant risks including potential dilution and the threat of delisting if compliance is not met by June 2026.

H&G High Conviction Limited has been suspended from ASX trading due to failing to meet operational requirements, raising questions about its future as a listed entity.

Immutep Limited’s shares have resumed trading following the release of an interim futility analysis from its pivotal TACTI-004 Phase III trial of eftilagimod alfa.

Manhattan Gold Limited has clarified recent share price and volume spikes, attributing them to strategic corporate communications and a fresh investor research report.

Oncosil Medical Ltd’s OSLOE securities have been suspended from trading by the ASX due to non-compliance with listing rules, raising questions about the company’s next steps.